Medical Weight Loss for Lubbock, Texas Residents
Lubbock, Texas residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month · just $5.50/day, serving Lubbock through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Lubbock Residents Choose New Hope Weight Loss
Lubbock patients choose New Hope Weight Loss because a named physician, Dr. Anjmun Sharma, M.D., oversees every case, pricing is transparent (semaglutide from $166/month, tirzepatide from $233/month · just $7.70/day), and the entire program runs by telehealth from our Costa Mesa, California clinic, which has served over 5,400 patients across Texas and beyond since 2020.
If you are searching for medical weight loss in Lubbock, New Hope Weight Loss treats patients statewide by telehealth from our Costa Mesa, California clinic. Dr. Sharma reviews your history by secure video and, if appropriate, prescribes compounded semaglutide or tirzepatide shipped to you.
Although our clinic is physically in Costa Mesa, California, Lubbock residents receive the same physician-supervised care without leaving Texas. We care for patients throughout Downtown, the Tech Terrace, and the greater South Plains region. There is no distance surcharge for Lubbock patients, and HSA, FSA, Klarna, and Affirm are all accepted.
For Lubbock residents, being seen by video means starting this week instead of waiting for an in-person appointment. Pricing for Lubbock is the same as everywhere: $119 for the review, $166/month for semaglutide, and $233/month for tirzepatide, with medication billed separately.
GLP-1 Weight Loss Programs Available
Two GLP-1 programs for Lubbock
Compounded semaglutide starts at $166/month (a 90-day program is $499) and uses the same active ingredient as Wegovy® and Ozempic®, which produced 15-17% average body-weight loss in clinical trials. Compounded tirzepatide starts at $233/month and uses a dual GLP-1/GIP mechanism shown to reach up to 22.5% in trials.
Every plan begins with a $119 physician review. Medication is billed separately, and HSA, FSA, Klarna, and Affirm are all accepted, with no distance surcharge.
How Telehealth Works for Lubbock
First, you complete the online medical intake in a few minutes. Next, Dr. Sharma reviews your history by secure video, usually within 48 hours. If you are a candidate and telehealth-eligible, your compounded medication ships to your Lubbock address in cold-pack packaging, and follow-ups and dose adjustments continue by video, with no travel.
Frequently Asked Questions, Lubbock
How do I get treatment from Lubbock?
As a Lubbock, Texas patient you connect with our Costa Mesa, California clinic by telehealth. Dr. Sharma oversees your plan by secure video and compounded medication ships to your home; eligibility is confirmed during the consultation.
Can I do this without an in-person visit from Lubbock?
Yes, it is fully telehealth. Your review, prescription, and follow-up are remote, with medication shipped to Lubbock in cold-pack packaging, no lines and no drive.
How much does it cost for Lubbock patients?
A $119 physician review, then compounded semaglutide from $166/month or tirzepatide from $233/month (medication separate). HSA, FSA, Klarna, and Affirm are accepted, and there is never a distance surcharge.
What areas of Lubbock do you serve?
We serve patients from across Lubbock by telehealth, including Downtown, the Tech Terrace, and the greater South Plains region.
How does telehealth treatment work for Lubbock patients?
You complete the online medical intake, Dr. Sharma reviews your history by secure video, typically within 48 hours, and if you are a candidate and telehealth-eligible, compounded medication ships to your Lubbock address. Follow-ups also happen by video.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Lubbock, Texas by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.